Ocular Therapeutix Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Ocular Therapeutix Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- OCUL
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001393434
Board of directors
-
Adrienne L. Graves · DirectorSince 2023
-
Antony C. Mattessich · Director · President and CEOSince 2023
-
Charles M. Warden · DirectorSince 2023
-
Jeffrey S. Heier · DirectorSince 2023
-
Leslie J. Williams · DirectorSince 2023
-
Merilee Raines · DirectorSince 2023
-
Pravin Dugel · Director · See RemarksSince 2024
-
Richard L. Lindstrom M.D. · DirectorSince 2023
-
Seung Suh Hong · DirectorSince 2023
Chief executives
Antony C. Mattessich
· President and CEO
Dates unknown
Board connections
4 of this board's directors also sit on 6 other boards.
- via Antony C. Mattessich
- via Adrienne L. Graves
- via Richard L. Lindstrom M.D.
- via Adrienne L. Graves
- via Merilee Raines
- via Merilee Raines
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $461,354
- 1 purchase by 1 insider
- Sold, last 12 months
- $3,088,461
- 24 sales by 8 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Pravin Dugel Director, Officer (See Remarks) | Gift | −50,092 | — | — |
| Jun 16, 2026 | Pravin Dugel Director, Officer (See Remarks) | Gift | +50,092 | — | — |
| Jun 10, 2026 | Charles M. Warden Director | Grant or award | +14,000 | — | — |
| Jun 10, 2026 | Adrienne L. Graves Director | Grant or award | +14,000 | — | — |
| Jun 10, 2026 | Robins Jason Shand Officer (Chief Financial Officer) | Grant or award | +15,441 | — | — |
| Jun 10, 2026 | Seung Suh Hong Director | Grant or award | +14,000 | — | — |
| Jun 10, 2026 | Richard L. Lindstrom M.D. Director | Grant or award | +14,000 | — | — |
| Jun 10, 2026 | Merilee Raines Director | Grant or award | +14,000 | — | — |
| Jun 10, 2026 | Leslie J. Williams Director | Grant or award | +14,000 | — | — |
| Jun 3, 2026 | Waheed Nadia Officer (Chief Medical Officer) | Open-market sale | −14,828 | $8.27 | $122,628 |
| May 28, 2026 | Pravin Dugel Director, Officer (See Remarks) | Gift | −394,696 | — | — |
| May 28, 2026 | Pravin Dugel Director, Officer (See Remarks) | Gift | +394,696 | — | — |
| May 26, 2026 | Pravin Dugel Director, Officer (See Remarks) | Open-market sale | −21,156 | $8.20 | $173,479 |
| May 26, 2026 | Kaiser Peter Officer (Chief Development Officer) | Open-market sale | −2,967 | $8.20 | $24,329 |
| May 26, 2026 | Jeffrey S. Heier Officer (Chief Scientific Officer) | Open-market sale | −3,018 | $8.20 | $24,748 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.